Analyst Alerts: Wynn Resorts, Bed Bath & Beyond, MAKO Surgical, Electronic Arts, Marina Biotech May 8th
Electronic Arts Inc. (NASDAQ:EA): Citigroup lowered its estimates and price target for Electronic Arts following the company’s Q4 results but believes the valuation remains compelling levels. The firm reiterates a Buy rating on the stock.
Wynn Resorts Ltd. (NASDAQ:WYNN): Deutsche Bank believes Wynn’s current valuation provides an attractive entry point following the company’s Q1 results. The firm expects consensus estimates to come down but raised its price target to reflect recent developments in Cotai. Deutsche keeps a Buy rating on the stock.
Bed Bath & Beyond, Inc. (NASDAQ:BBBY): Deutsche Bank believes Bed Bath & Beyond (NASDAQ:BBBY) will fare better than Green Mountain (NASDAQ:GMCR) after its channel checks indicated no clearance on the company’s coffee K-cups outside of cider and cocoa. The firm keeps a Buy rating on Bed Bath shares with a $75 price target.
MAKO Surgical Corp. (NASDAQ:MAKO): Piper Jaffray said it would be an aggressive buyer of Mako Surgical shares on the pullback post the company’s Q1 results and lowered robot guidance. The firm believes the Mako’s multi-year growth story remains intact and keeps an Overweight rating on the stock with a lowered price target of $49.
Marina Biotech, Inc. (NASDAQ:MRNA): Marina Biotech (NASDAQ:MRNA) announced that it has entered into an exclusive licensing agreement with Monsanto (NYSE:MON) for Marina Biotech’s delivery and chemistry technologies. Terms of the agreement were not disclosed.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.